Navigation Links
Risk aversity visible in the brain
Date:11/26/2012

Some people live their lives by the motto "no risk - no fun!" and avoid hardly any risks. Others are clearly more cautious and focus primarily on safety when investing and for other business activities. Scientists from the University of Bonn in cooperation with colleagues from the University of Zurich studied the attitudes towards risk in a group of 56 subjects. They found that in people who preferred safety, certain regions of the brain show a higher level of activation when they are confronted with quite unforeseeable situations. In addition, they do not distinguish as clearly as risk takers whether a situation is more or less risky than expected. The results have just been published in the renowned "Journal of Neuroscience."

"We were especially interested in the link between risk preferences and the brain regions processing this information," says Prof. Dr. Bernd Weber from the Center for Economics and Neuroscience (CENs) at the University of Bonn. First, the researchers tested a total of 56 subjects for their willingness to take risks. "In an economic game, the test subjects had a choice between a secured payout and a lottery," reports Sarah Rudorf from CENs, the study's principal author. Those who showed a strong preference for the lottery in this test were categorized as risk takers. Others preferred the secured payout even if the lottery's odds of winning were clearly better. They were put in the risk-averse group.

In risk-averse individuals, certain regions of the brain are activated more strongly

Then the test subjects played a card game in a brain scanner to study their risk perception. Cards carrying numbers from one to ten were shown on the video glasses in front of their eyes. Each time, two cards were randomly drawn. Before the subjects were shown the cards, they were asked to place bets on whether the second card would have a higher or a lower number than the first one. "The statistical probability for either case to occur is always the same: fifty-fifty," says Prof. Weber. "This is important so that all subjects, whether they are risk takers or not, experience risky situations inside the scanner." They were not able to assess their probability of winning their bet until they saw the first card. Here, the researchers found that in the subjects who tended to avoid risks, two specific regions of the brain were activated more strongly than in those who were willing to take risks. These areas are the ventral striatum and the insular cortex. The ventral striatum reacts both to the probability of winning, as well as to how well an individual can predict the outcome of the bet. The insular cortex is particularly sensitive to the risk a situation carries, and for whether it is higher or lower than anticipated.

Risk seekers adjust their strategy after lucky streaks

Sarah Rudorf summarized the results, "Individuals in whom these regions of the brain are activated at a higher level seem to perceive risks more clearly and assess them as more negative than those who are willing to take risks." Risk-averse individuals seem to overestimate the consequences of risk, and they did not distinguish as clearly between situations that turned out to be more or less risky than expected. In contrast, the test subjects who tended to take greater risks also focused their behavior more towards the wins and losses, and more clearly changed their strategy after negative situations.

Study is first to show the neurobiological mechanisms

"This study is the first to show the neurobiological mechanisms of how individual risk preferences determine risk perception," says Prof. Weber. "This also has effects on behavior in the areas of finance and health."

In a next step, the researchers want to study the consequences these results have on economic decisions such as in the stock market. "This might even allow improving the advising process for investors with regard to their individual risk behavior," says Prof. Weber. And he considers health another important area. Smokers know that what they do is very dangerous, and yet they smoke. "If we learned more about smokers' attitudes towards risk, we might be able to provide information for developing better anti-smoking campaigns."


'/>"/>

Contact: Bernd Weber
bernd.weber@ukb.uni-bonn.de
49-228-738-290
University of Bonn
Source:Eurekalert

Related medicine news :

1. Research: NCAA football exploits players in invisible labor market
2. Study Suggests Vaccine May Help Kids With Brain Cancer
3. Epilepsy Leads to More Brain Abnormalities Over Time
4. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
5. Why is traumatic brain injury increasing among the elderly?
6. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
7. Dental X-Rays May Be Linked to Benign Brain Tumors
8. Nonsurgical Method to Measure Brain Pressure Shows Promise
9. Researchers Map Brain Regions Linked to Intelligence
10. Football-related catastrophic brain injuries on the rise
11. Brain Tumor Vaccine Shows Promise in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
Breaking Medicine Technology: